Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam vs etomidate vs propofol before CABG surgery
IRCT20120215009014N391Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronary arteriosclerosis comparing Midazolam, Etomidate and Propofol (3 arms). Primary endpoints: Heart rate, Systolic blood pressure and 3 more. Started May 2021; status: completed.
02
Drugs
midazolametomidatepropofol
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20120215009014N391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N391.